Contact Information: CONTACT: Bobbie Volman MMR Information Systems, Inc. (310) 476-7002, Ext. 2005 bvolman@mmrmail.com Michael Selsman Public Communications Co. (310) 553-5732 ms@publiccommunications.biz
MMR Information Systems Engages Global Research Services as Advisor to Accelerate Time to Market for Anti-CD20 Monoclonal Antibodies
| Source: MMR Information Systems, Inc.
LOS ANGELES, CA--(Marketwire - November 4, 2009) - MMR Information Systems, Inc. (OTCBB : MMRF )
www.mymedicalrecords.com, announced today it has retained Global Research
Services LLC, www.grs-cro.com, a full-service clinical trials management
organization, to assist the Company in its efforts to accelerate bringing
to market its patented anti-CD20 monoclonal antibodies. Anti-CD20
antibodies are useful in treating B-Cell malignancies, including
Non-Hodgkin Lymphoma (NHL) and additional B-Cell mediated conditions such
as rheumatoid arthritis. Global Research Services specializes in serving
sponsors of Phase I-IV research. MMRF's anti-CD20 antibody asset is
potentially a candidate for the next generation Rituximab, marketed under
the trade name Rituxan® in the United States by Biogen Idec and Genentech
(wholly owned member of the Roche Group) and under the name MabThera® by
Roche in the rest of the world except Japan, where it is co-marketed by
Chugai and Zenyaku Kogyo Co. Ltd. Rituxan is one of the world's most
successful monoclonal antibodies with reported total sales in 2008 in
excess of US $5.4 billion.
MMR Information Systems recently filed for extension of the Company's
Patent Cooperation Treaty (PCT) patent application on anti-CD20 monoclonal
antibodies to the national phase through filings in major European, Asian,
North American, and South American markets.
Global Research Services operates from offices and/or presence on the
ground across six continents of the world, with experience in over 135
protocols with 35 Sponsors in 3400 investigational sites, encompassing all
aspects of clinical trials management. The Global team has extensive
experience in designing, developing and implementing clinical development
programs that accelerate time-to-market for a wide range of new drugs,
biologics and medical devices. Global Research Services provides full
services from Phase I through final regulatory approval and ultimate
commercialization.
Robert H. Lorsch, Chairman and CEO of MMR Information Systems, Inc., noted,
"In the Personal Health Records business, the buzzword is 'meaningful use.'
With regard to the fighting of cancer, the buzzword could be a 'meaningful
difference.' Our health information products have meaning for meaningful
use, and we look forward to the possibility that our anti-CD20 antibodies
can make a meaningful difference."
About MMR Information Systems, Inc.
MMR Information Systems, Inc. (OTCBB : MMRF ), through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic safe
deposit box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, unions and professional organizations and
affinity groups. MyMedicalRecords enables individuals and families to
access their medical records and other important documents, such as birth
certificates, passports, insurance policies and wills anytime from anywhere
using the Internet. The MyMedicalRecords Personal Health Record is built on
proprietary, patented technologies to allow documents, images and voicemail
messages to be transmitted and stored in the system using a variety of
methods, including fax, phone, or file upload without relying on any
specific electronic medical record platform to populate a user's account.
The Company's professional offering, MMRPro, is designed to give
physicians' offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients in real time.
MMR is an Independent Software Vendor Partner with Kodak to deliver an
integrated turnkey EMR solution for small to mid-size physician practices.
MMR clients include AFL-CIO, Alexian Brothers Hospital Network, Coverdell,
LegalZoom, The Latino Coalition, MedicAlert, NRA, Qvisory, XN Financial and
others. MMR is also an integrated service provider on Google Health. To
learn more about MMR Information Systems, Inc. visit
www.mmrinformationsystems.com.
About GRSworldwide
Global Research Services (GRS) is an international clinical research
organization supplying a
full range of clinical trial services to pharmaceutical, biotech, and
medical device companies. Headquartered in Maryland, GRS operates offices
in
North America, South America, Europe and Asia
and helps clients worldwide complete their clinical development programs
through a global site
network, experienced staff, effective management plans and premier
capabilities. www.grs-cro.com.
Forward-Looking Statements
Statements in this press release that are not strictly historical in nature
constitute "forward-looking statements." Such statements include, but are
not limited to, statements regarding the Company's anti-CD20 antibody
assets. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause actual results to be
materially different from historical results or from any results expressed
or implied by such forward-looking statements. These factors include, but
are not limited to, risks and uncertainties related to the development and
approval of biotechnology and biopharmaceutical product candidates and
additional risks discussed in the Company's filings with the Securities and
Exchange Commission. All subsequent written and oral forward-looking
statements attributable to the Company (or any person acting on the
Company's behalf) are qualified by the cautionary statements in this
notice. MMR Information Systems, Inc. is providing this information as of
the date of this release and, except as required by law, does not undertake
any obligation to update any forward-looking statements contained in this
release as a result of new information, future events or otherwise.